![Frontiers | Phenotypic and Immunometabolic Aspects on Stem Cell Memory and Resident Memory CD8+ T Cells Frontiers | Phenotypic and Immunometabolic Aspects on Stem Cell Memory and Resident Memory CD8+ T Cells](https://www.frontiersin.org/files/Articles/884148/fimmu-13-884148-HTML/image_m/fimmu-13-884148-g001.jpg)
Frontiers | Phenotypic and Immunometabolic Aspects on Stem Cell Memory and Resident Memory CD8+ T Cells
![Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.add8454/asset/df0c16c2-02b4-4ff0-a3a6-edb7654cd72e/assets/images/large/sciimmunol.add8454-f2.jpg)
Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology
![Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy | Nature Communications Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-023-37874-2/MediaObjects/41467_2023_37874_Fig1_HTML.png)
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy | Nature Communications
![Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity: Molecular Therapy Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity: Molecular Therapy](https://www.cell.com/cms/attachment/94e334d5-fc85-4ff8-bf26-0f853a9e44f0/gr2.jpg)
Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity: Molecular Therapy
![PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial | Nature Medicine PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01726-1/MediaObjects/41591_2022_1726_Fig1_HTML.png)
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial | Nature Medicine
![Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.add8454/asset/1cff3195-a838-4056-afd1-339fcb00a486/assets/images/large/sciimmunol.add8454-f3.jpg)
Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology
![Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India | Bone Marrow Transplantation Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-022-01866-5/MediaObjects/41409_2022_1866_Figa_HTML.png)
Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India | Bone Marrow Transplantation
Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19 | Aging
![Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India | Bone Marrow Transplantation Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India | Bone Marrow Transplantation](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41409-022-01866-5/MediaObjects/41409_2022_1866_Fig1_HTML.png)
Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India | Bone Marrow Transplantation
![Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.add8454/asset/06dd8300-2455-48e2-9b88-dc88851dac2a/assets/images/large/sciimmunol.add8454-f4.jpg)
Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology
![Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.add8454/asset/79c8e60b-9d21-497b-a23a-2b924a844365/assets/images/large/sciimmunol.add8454-f1.jpg)